 Hepatitis C
"Hepatitis C" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally, and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
| Descriptor ID |
D006526
|
| MeSH Number(s) |
C02.440.440 C02.782.350.350 C06.552.380.705.440
|
| Concept/Terms |
Hepatitis C- Hepatitis C
- Parenterally-Transmitted Non-A, Non-B Hepatitis
- Parenterally Transmitted Non A, Non B Hepatitis
- PT-NANBH
- Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis C".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis C".
This graph shows the total number of publications written about "Hepatitis C" by people in this website by year, and whether "Hepatitis C" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 1 | 1 | | 1995 | 1 | 0 | 1 | | 2000 | 1 | 0 | 1 | | 2001 | 1 | 1 | 2 | | 2002 | 2 | 1 | 3 | | 2003 | 4 | 2 | 6 | | 2004 | 6 | 2 | 8 | | 2005 | 7 | 1 | 8 | | 2006 | 6 | 3 | 9 | | 2007 | 4 | 4 | 8 | | 2008 | 2 | 1 | 3 | | 2009 | 4 | 2 | 6 | | 2010 | 5 | 0 | 5 | | 2011 | 7 | 3 | 10 | | 2012 | 2 | 2 | 4 | | 2013 | 5 | 0 | 5 | | 2014 | 3 | 2 | 5 | | 2015 | 14 | 2 | 16 | | 2016 | 8 | 1 | 9 | | 2017 | 9 | 2 | 11 | | 2018 | 6 | 1 | 7 | | 2019 | 7 | 0 | 7 | | 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hepatitis C" by people in Profiles.
-
McGrew C, MacCallum DS, Narducci D, Nuti R, Calabrese L, Dimeff R, Paul S, Poddar SK, Rao A, McKeag D. AMSSM Position Statement Update: Blood-Borne Pathogens in the Context of Sports Participation. Clin J Sport Med. 2020 07; 30(4):283-290.
-
Koullias Y, Hammond SP. The Promise of Direct-Acting Antiviral Therapies to Improve Care and Outcomes in Patients With Cancer Who Have Chronic Hepatitis C Infection. J Oncol Pract. 2019 12; 15(12):639-640.
-
Kiser JJ. Safety of Hepatitis C Viral Protease Inhibitors in Compensated Cirrhotics: Lingering Concerns Put to Rest? Clin Infect Dis. 2019 10 30; 69(10):1665-1666.
-
Rowan SE, Muething L, Spielmann K, Blum J, Lou Y, Vaughn S, Burman WJ. The Yield of Birth Cohort Screening for Hepatitis C in Community Health Centers. J Gen Intern Med. 2019 10; 34(10):2003-2004.
-
Naggie S, Fierer DS, Hughes MD, Kim AY, Luetkemeyer A, Vu V, Roa J, Rwema S, Brainard DM, McHutchison JG, Peters MG, Kiser JJ, Marks KM, Chung RT. Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals. Clin Infect Dis. 2019 07 18; 69(3):514-522.
-
Abara WE, Trujillo L, Broz D, Finlayson T, Teshale E, Paz-Bailey G, Glick S, Al-Tayyib AA, Robinson WT, Masiello-Schuette S, Sey EK, Anderson BJ, Poe J, Braunstein S. Age-Related Differences in Past or Present Hepatitis C Virus Infection Among People Who Inject Drugs: National Human Immunodeficiency Virus Behavioral Surveillance, 8 US Cities, 2015. J Infect Dis. 2019 07 02; 220(3):377-385.
-
Fischer BG, Baduashvili A, Evans AT. Evaluation for Fibrosis After Cure of Hepatitis C. JAMA. 2019 04 16; 321(15):1534.
-
Wyles D, Weiland O, Yao B, Weilert F, Dufour JF, Gordon SC, Stoehr A, Brown A, Mauss S, Zhang Z, Pilot-Matias T, Rodrigues L, Mensa FJ, Poordad F. Retreatment of patients who failed glecaprevir/pibrentasvir treatment for hepatitis C virus infection. J Hepatol. 2019 05; 70(5):1019-1023.
-
Rockstroh JK, Lacombe K, Viani RM, Orkin C, Wyles D, Luetkemeyer AF, Soto-Malave R, Flisiak R, Bhagani S, Sherman KE, Shimonova T, Ruane P, Sasadeusz J, Slim J, Zhang Z, Samanta S, Ng TI, Gulati A, Kosloski MP, Shulman NS, Trinh R, Sulkowski M. Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study. Clin Infect Dis. 2018 09 14; 67(7):1010-1017.
-
Chan C, Schiano T, Agudelo E, Paul Haydek J, Hoteit M, Laurito MP, Norvell JP, Terrault N, Verna EC, Yang A, Levitsky J. Immune-mediated graft dysfunction in liver transplant recipients with hepatitis C virus treated with direct-acting antiviral therapy. Am J Transplant. 2018 10; 18(10):2506-2512.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|